2-(3-Aminophenyl)-1H-benzo[d]imidazol-6-amine

Catalog No.: 
ACXNMC527
CAS No.: 
13676-49-8
Molecular Formula: 
C13H12N4
Molecular Weight: 
224.27
2-(3-Aminophenyl)-1H-benzo[d]imidazol-6-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$96.00In stockInquiry
100g95%$295.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Aminophenyl)-1H-benzo[d]imidazol-6-amine
IUPAC Name2-(3-aminophenyl)-1H-benzo[d]imidazol-6-amine
MDL No.MFCD13874743
Molecular FormulaC13H12N4
Molecular Weight224.27
SMILESNC1=CC=C2C(NC(C3=CC=CC(N)=C3)=N2)=C1
InChI KeyQCILMAMLEHOLRX-UHFFFAOYSA-N
Synonym2-(3-aminophenyl)-5-aminobenzimidazole;2-(3-Aminophenyl)-1H-benzo[d]imidazol-6-amine;1H-Benzimidazol-5-amine, 2-(3-aminophenyl)-;2-(3-aminophenyl)-3H-benzimidazol-5-amine;2,3,5-ABA;1H-Benzimidazol-6-amine, 2-(3-aminophenyl)-;3-(3-aminophenyl)-5-aminobenzimi dazole (2,3,5-ABA);2-(3'-aminophenyI)- -5- -aminobenzimidazole
CAS No.13676-49-8
PubChem CID46281

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACXNMC527 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXNMC527 route product structure diagram
    ACXNMC52713676-49-8In Stock
Inquiry

2. ACXNMC527 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXNMC527 route product structure diagram
    ACXNMC52713676-49-8In Stock
Inquiry

3. ACXNMC527 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXNMC527 route product structure diagram
    ACXNMC52713676-49-8In Stock
Inquiry

Comments (0)